Načítá se...
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
BACKGROUND AND AIMS: It is unclear whether direct-acting antiviral (DAA) treatment-induced sustained virologic response (SVR) reduces the risk of hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV) infection. We aimed to determine the impact of DAA-induced SVR on HCC risk. METHOD...
Uloženo v:
| Vydáno v: | J Hepatol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5837901/ https://ncbi.nlm.nih.gov/pubmed/28887168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2017.08.030 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|